Skip to main content

Advertisement

SpringerLink
Log in

Protective Roles of Xenotropic and Polytropic Retrovirus Receptor 1 (XPR1) in Uremic Vascular Calcification

  • Original Research
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

Cellular phosphate transporters play critical roles in the pathogenesis of vascular calcification (VC) in chronic kidney disease (CKD). However, the mechanistic link between VC and xenotropic and polytropic receptor 1 (XPR1), a newly identified phosphate exporter, remains unknown. We developed a new mouse model with rapidly progressive uremic VC in C57BL/6 mice and examined the roles of XPR1. The combination of surgical heminephrectomy and 8 weeks of feeding a customized warfarin and adenine-based diet induced extensive aortic VC in almost all mice. The XPR1 mRNA level in the aorta of CKD mice was significantly lower than those in control mice as early as week 2, when there was no apparent VC, which progressively declined thereafter. Dietary phosphate restriction increased XPR1 mRNA expression in the aorta but reduced aortic VC in CKD mice. In cultured vascular smooth muscle cells (VSMCs), a calcifying medium supplemented with high phosphate and calcium did not affect XPR1 mRNA expression. The XPR1 mRNA expression in cultured VCMCs was also unaffected by administration of indoxyl sulfate or calcitriol deficiency but was decreased by 1–34 parathyroid hormone or fibroblast growth factor 23 supplementation. Furthermore, XPR1 deletion in the cultured VSMCs exacerbated calcification of the extracellular matrix as well as the osteogenic phenotypic switch under the condition of calcifying medium. Our data suggest that XPR1 plays protective roles in the pathogenesis of VC and its decrease in the aorta may contribute to the progression of VC in CKD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data Availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Code Availability

Software application or custom code used in this study is available from the corresponding author upon reasonable request.

References

  1. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H (2003) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18(9):1731–1740. https://doi.org/10.1093/ndt/gfg414

    Article  PubMed  Google Scholar 

  2. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM (2001) Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38(4):938–942. https://doi.org/10.1161/hy1001.096358

    Article  CAS  PubMed  Google Scholar 

  3. Adragao T, Pires A, Lucas C, Birne R, Magalhaes L, Gonçalves M, Negrao AP (2004) A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant 19(6):1480–1488. https://doi.org/10.1093/ndt/gfh217

    Article  PubMed  Google Scholar 

  4. Giachelli CM (2003) Vascular calcification: in vitro evidence for the role of inorganic phosphate. J Am Soc Nephrol 14(9 Suppl 4):S300–S304. https://doi.org/10.1097/01.asn.0000081663.52165.66

    Article  CAS  PubMed  Google Scholar 

  5. Lau WL, Linnes M, Chu EY, Foster BL, Bartley BA, Somerman MJ, Giachelli CM (2013) High phosphate feeding promotes mineral and bone abnormalities in mice with chronic kidney disease. Nephrol Dial Transplant 28(1):62–69. https://doi.org/10.1093/ndt/gfs333

    Article  CAS  PubMed  Google Scholar 

  6. Cozzolino M, Staniforth ME, Liapis H, Finch J, Burke SK, Dusso AS, Slatopolsky E (2003) Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia. Kidney Int 64(5):1653–1661. https://doi.org/10.1046/j.1523-1755.2003.00284.x

    Article  CAS  PubMed  Google Scholar 

  7. Adeney KL, Siscovick DS, Ix JH, Seliger SL, Shlipak MG, Jenny NS, Kestenbaum BR (2009) Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol 20(2):381–387. https://doi.org/10.1681/ASN.2008040349

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Opdebeeck B, Maudsley S, Azmi A, Maré AD, Leger WD, Meijers B, Verhulst A et al (2019) Indoxyl sulfate and p-cresyl sulfate promote vascular calcification and associate with glucose intolerance. J Am Soc Nephrol 30(5):751–766. https://doi.org/10.1681/ASN.2018060609

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. He X, Jiang H, Gao F, Liang S, Wei M, Chen L (2019) Indoxyl sulfate-induced calcification of vascular smooth muscle cells via the PI3K/Akt/NF-κB signaling pathway. Microsc Res Tech 82(12):2000–2006. https://doi.org/10.1002/jemt.23369

    Article  CAS  PubMed  Google Scholar 

  10. Hu MC, Shi M, Zhang J, Quinones H, Griffith C, Kuro-o M, Moe OW (2011) Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 22(1):124–136. https://doi.org/10.1681/ASN.2009121311

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. O’Neill WC, Lomashvili KA, Malluche HH, Faugere MC, Riser BL (2011) Treatment with pyrophosphate inhibits uremic vascular calcification. Kidney Int 79(5):512–517. https://doi.org/10.1038/ki.2010.461

    Article  CAS  PubMed  Google Scholar 

  12. Bennett BJ, Scatena M, Kirk EA, Rattazzi M, Varon RM, Averill M, Schwartz SM et al (2006) Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice. Arterioscler Thromb Vasc Biol 26(9):2117–2124. https://doi.org/10.1161/01.ATV.0000236428.91125.e6

    Article  CAS  PubMed  Google Scholar 

  13. Yamada S, Tokumoto M, Tsuruya K, Tatsumoto N, Noguchi H, Kitazono T, Ooboshi H (2015) Fetuin-A decrease induced by a low-protein diet enhances vascular calcification in uremic rats with hyperphosphatemia. Am J Physiol Renal Physiol 309(8):744–754. https://doi.org/10.1152/ajprenal.00017.2015

    Article  CAS  Google Scholar 

  14. Yamada S, Tokumoto M, Tatsumoto N, Taniguchi M, Noguchi H, Nakano T, Masutani K et al (2014) Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia. Am J Physiol Renal Physiol 306(12):1418–1428. https://doi.org/10.1152/ajprenal.00633.2013

    Article  CAS  Google Scholar 

  15. Yamada S, Taniguchi M, Tokumoto M, Toyonaga J, Fujisaki K, Suehiro T, Noguchi H et al (2012) The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease. J Bone Miner Res 27(2):474–485. https://doi.org/10.1002/jbmr.539

    Article  CAS  PubMed  Google Scholar 

  16. Zhao MM, Xu MJ, Cai Y, Zhao G, Guan Y, Kong W, Tang C et al (2011) Mitochondrial reactive oxygen species promote p65 nuclear translocation mediating high-phosphate-induced vascular calcification in vitro and in vivo. Kidney Int 79(10):1071–1079. https://doi.org/10.1038/ki.2011.18

    Article  CAS  PubMed  Google Scholar 

  17. Carracedo M, Artiach G, Arnardottir H, Back M (2019) The resolution of inflammation through omega-3 fatty acids in atherosclerosis, intimal hyperplasia, and vascular calcification. Semin Immunopathol 41(6):757–766. https://doi.org/10.1007/s00281-019-00767-y

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Sanchez-Duffhues G, Garcia de Vinuesa A, van de Pol V, Geerts ME, de Vries MR, Janson SG, van Dam H et al (2019) Inflammation induces endothelial-to-mesenchymal transition and promotes vascular calcification through downregulation of BMPR2. J Pathol 247(3):333–346. https://doi.org/10.1002/path.5193

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Chavkin NW, Chia JJ, Crouthamel MH, Giachelli CM (2015) Phosphate uptake-independent signaling functions of the type III sodium-dependent phosphate transporter, PiT-1, in vascular smooth muscle cells. Exp Cell Res 333(1):39–48. https://doi.org/10.1016/j.yexcr.2015.02.002

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Yamada S, Leaf EM, Chia JJ, Cox TC, Speer MY, Giachelli CM (2018) PiT-2, a type III sodium-dependent phosphate transporter, protects against vascular calcification in mice with chronic kidney disease fed a high-phosphate diet. Kidney Int 94(4):716–727. https://doi.org/10.1016/j.kint.2018.05.015

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Giovannini D, Touhami J, Charnet P, Sitbon M, Battini JL (2013) Inorganic phosphate export by the retrovirus receptor XPR1 in metazoans. Cell Rep 3(6):1866–1873. https://doi.org/10.1016/j.celrep.2013.05.035

    Article  CAS  PubMed  Google Scholar 

  22. Yao XP, Zhao M, Wang C, Guo XX, Su H, Dong EL, Chen HT et al (2017) Analysis of gene expression and functional characterization of XPR1: a pathogenic gene for primary familial brain calcification. Cell Tissue Res 370(2):267–273. https://doi.org/10.1007/s00441-017-2663-3

    Article  CAS  PubMed  Google Scholar 

  23. Legati A, Giovannini D, Nicolas G, Lopez-Sanchez U, Quintans B, Oliveira JR, Sears RL et al (2015) Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export. Nat Genet 47(6):579–581. https://doi.org/10.1038/ng.3289

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Lopez-Sanchez U, Tury S, Nicolas G, Wilson MS, Jurici S, Ayrignac X, Courgnaud V et al (2020) Interplay between primary familial brain calcification-associated SLC20A2 and XPR1 phosphate transporters requires inositol polyphosphates for control of cellular phosphate homeostasis. J Biol Chem 295(28):9366–9378. https://doi.org/10.1074/jbc.RA119.011376

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G (1997) Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386(6620):78–81. https://doi.org/10.1038/386078a0

    Article  CAS  PubMed  Google Scholar 

  26. O’Young J, Liao Y, Xiao Y, Jalkanen J, Lajoie G, Karttunen M, Goldberg HA et al (2011) Matrix Gla protein inhibits ectopic calcification by a direct interaction with hydroxyapatite crystals. J Am Chem Soc 133(45):18406–18412. https://doi.org/10.1021/ja207628k

    Article  CAS  PubMed  Google Scholar 

  27. Kawata T, Nagano N, Obi M, Miyata S, Koyama C, Kobayashi N, Wakita S et al (2008) Cinacalcet suppresses calcification of the aorta and heart in uremic rats. Kidney Int 74(10):1270–1277. https://doi.org/10.1038/ki.2008.407

    Article  CAS  PubMed  Google Scholar 

  28. Ter Braake AD, Smit AE, Bos C, van Herwaarden AE, Alkema W, van Essen HW, Bravenboer N et al (2020) Magnesium prevents vascular calcification in Klotho deficiency. Kidney Int 97(3):487–501. https://doi.org/10.1016/j.kint.2019.09.034

    Article  CAS  PubMed  Google Scholar 

  29. Diaz-Tocados JM, Peralta-Ramirez A, Rodriguez-Ortiz ME, Raya AI, Lopez I, Pineda C, Herencia C et al (2017) Dietary magnesium supplementation prevents and reverses vascular and soft tissue calcifications in uremic rats. Kidney Int 92(5):1084–1099. https://doi.org/10.1016/j.kint.2017.04.011

    Article  CAS  PubMed  Google Scholar 

  30. Sakaguchi Y, Hamano T, Obi Y, Monden C, Oka T, Yamaguchi S, Matsui I et al (2019) A randomized trial of magnesium oxide and oral carbon absorbent for coronary artery calcification in predialysis CKD. J Am Soc Nephrol 30(6):1073–1085. https://doi.org/10.1681/ASN.2018111150

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Li X, Gu C, Hostachy S, Sahu S, Wittwer C, Jessen HJ, Fiedler D et al (2020) Control of XPR1-dependent cellular phosphate efflux by InsP8 is an exemplar for functionally-exclusive inositol pyrophosphate signaling. Proc Natl Acad Sci USA 117(7):3568–3574. https://doi.org/10.1073/pnas.1908830117

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Xu X, Li X, Sun H, Cao Z, Gao R, Niu T, Wang Y et al (2020) Murine placental-fetal phosphate dyshomeostasis caused by an Xpr1 deficiency accelerates placental calcification and restricts fetal growth in late gestation. J Bone Miner Res 35(1):116–129. https://doi.org/10.1073/pnas.1908830117

    Article  CAS  PubMed  Google Scholar 

  33. Kuro-o M (2013) A phosphate-centric paradigm for pathophysiology and therapy of chronic kidney disease. Kidney Int Supple 3(5):420–426. https://doi.org/10.1038/kisup.2013.88

    Article  CAS  Google Scholar 

  34. Ter Braake AD, Eelderink C, Zeper LW, Pasch A, Bakker SJL, de Borst MH, Hoenderop JGJ et al (2020) Calciprotein particle inhibition explains magnesium-mediated protection against vascular calcification. Nephrol Dial Transplant 35(5):765–773. https://doi.org/10.1093/ndt/gfz190

    Article  CAS  PubMed  Google Scholar 

  35. Sakaguchi Y, Hamano T, Matsui I, Oka T, Yamaguchi S, Kubota K, Shimada K et al (2019) Low magnesium diet aggravates phosphate-induced kidney injury. Nephrol Dial Transplant 34(8):1310–1319. https://doi.org/10.1093/ndt/gfy358

    Article  CAS  PubMed  Google Scholar 

  36. Omede F, Zhang S, Johnson C, Daniel E, Zhang Y, Fields TA, Boulanger J et al (2020) Dietary phosphate restriction attenuates polycystic kidney disease in mice. Am J Physiol Renal Physiol 318(1):35–42. https://doi.org/10.1152/ajprenal.00282.2019

    Article  CAS  Google Scholar 

  37. Damment S, Secker R, Shen V, Lorenzo V, Rodriguez M (2011) Long-term treatment with lanthanum carbonate reduces mineral and bone abnormalities in rats with chronic renal failure. Nephrol Dial Transplant 26(6):1803–1812. https://doi.org/10.1093/ndt/gfq682

    Article  CAS  PubMed  Google Scholar 

  38. Shuvy M, Abedat S, Eliaz R, Abu-Rmeileh I, Abu-Snieneh A, Ben-Dov IZ, Meir K et al (2019) Hyperphosphatemia is required for initiation but not propagation of kidney failure-induced calcific aortic valve disease. Am J Physiol Heart Circ Physiol 317(4):695–704. https://doi.org/10.1152/ajpheart.00765.2018

    Article  CAS  Google Scholar 

  39. Tani T, Orimo H, Shimizu A, Tsuruoka S (2017) Development of a novel chronic kidney disease mouse model to evaluate the progression of hyperphosphatemia and associated mineral bone disease. Sci Rep 7(1):2233. https://doi.org/10.1038/s41598-017-02351-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Yoshida T, Yamashita M, Horimai C, Hayashi M (2017) Smooth muscle-selective nuclear factor-κB inhibition reduces phosphate-induced arterial medial calcification in mice with chronic kidney disease. J Am Heart Assoc 6(11):e007248. https://doi.org/10.1161/JAHA.117.00724

    Article  PubMed  PubMed Central  Google Scholar 

  41. Van TV, Watari E, Taketani Y, Kitamura T, Shiota A, Tanaka T, Tanimura A et al (2012) Dietary phosphate restriction ameliorates endothelial dysfunction in adenine-induced kidney disease rats. J Clin Biochem Nutr 51(1):27–32. https://doi.org/10.3164/jcbn.11-96

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Dos Santos IF, Sheriff S, Amlal S, Ahmed RPH, Thakar CV, Amlal H (2019) Adenine acts in the kidney as a signaling factor and causes salt- and water-losing nephropathy: early mechanism of adenine-induced renal injury. Am J Physiol Renal Physiol 316(4):743–757. https://doi.org/10.1152/ajprenal.00142.2018

    Article  CAS  Google Scholar 

  43. Mace ML, Olgaard K, Lewin E (2020) New aspects of the kidney in the regulation of fibroblast growth factor 23 (FGF23) and mineral homeostasis. Int J Mol Sci 21(22):8810. https://doi.org/10.3390/ijms21228810

    Article  CAS  PubMed Central  Google Scholar 

  44. Edmonston D, Wolf M (2020) FGF23 at the crossroads of phosphate, iron economy and erythropoiesis. Nat Rev Nephrol 16(1):7–19. https://doi.org/10.1038/s41581-019-0189-5

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Mr. Mikio Munakata at the Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University and Dr. Hirotaka Iura at the Department of Orthopaedic Surgery, Kyushu University for supporting the experiments. We thank the Research Support Center and Kyushu University Graduate School of Medical Sciences for technical support. We also thank Mitchell Arico from Edanz Group (https://jp.edanz.com/ac) for editing a draft of this manuscript.

Funding

This study was supported by grants from the Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research 18H06224 and 19K08706) and the Kidney Foundation Japan [Grant for pathophysiological research conference in chronic kidney disease (JKFB 18-15)].

Author information

Authors and Affiliations

  1. Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi–Ku, Fukuoka, 8128582, Japan

    Hokuto Arase, Shunsuke Yamada, Toshiaki Nakano & Takanari Kitazono

  2. Department of Integrated Therapy for Chronic Kidney Disease, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 8128582, Japan

    Kumiko Torisu

  3. Department of Internal Medicine, Fukuoka Dental College, 2-15-1 Tamura, Sawara-Ku, Fukuoka, 8140193, Japan

    Masanori Tokumoto

  4. Fukuoka Renal Clinic, 4-6-20 Watanabe-Dori, Chuo-Ku, Fukuoka, 8100004, Japan

    Masatomo Taniguchi

  5. Department of Nephrology, Nara Medical University, 840 Shijo-Cho, Kashihara, Nara, 6348521, Japan

    Kazuhiko Tsuruya

Authors
  1. Hokuto Arase
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shunsuke Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kumiko Torisu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masanori Tokumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masatomo Taniguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kazuhiko Tsuruya
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Toshiaki Nakano
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Takanari Kitazono
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Research concept: HA, SY, and KTo; data analysis interpretation: HA, SY, KT, MTo, and MTa; supervision or mentorship: TN, KTs, and TK. Each author contributed important intellectual content during manuscript drafting or revision and accepts accountability for the overall work by ensuring that questions that pertain to the accuracy or integrity of any portion of the work are appropriately investigated and resolved. TN takes responsibility that this study has been reported honestly, accurately, and transparently, that no important aspects of the study have been omitted, and that any discrepancies from the study as planned have been explained.

Corresponding author

Correspondence to Toshiaki Nakano.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Human and Animal Rights and Informed Consent

All animal procedures and protocols were approved by the Ethics Committee on Animal Experimentation, Kyushu University Graduate School of Medical Sciences (approval number A30-203). This article does not contain any studies with human subjects or human tissues performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 57 kb)

Supplementary file2 (PPTX 1053 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Arase, H., Yamada, S., Torisu, K. et al. Protective Roles of Xenotropic and Polytropic Retrovirus Receptor 1 (XPR1) in Uremic Vascular Calcification. Calcif Tissue Int 110, 685–697 (2022). https://doi.org/10.1007/s00223-022-00947-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-022-00947-3

Keywords

Search

Navigation